Pharmaceuticals Stocks Scatter Chart

48 companies Industry in Healthcare P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 48 Pharmaceuticals stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 12.6% and the median P/E 15.58. Pinned to the edge: 2 outliers on X and 3 on Y.

Rank correlation -0.15 Trend R² 0.01 X middle half 4.7% to 30.7% Y middle half 6.86 to 41.34
8High Revenue Growth (1y) (TTM), high P/E
16Low Revenue Growth (1y) (TTM), high P/E
8Low Revenue Growth (1y) (TTM), low P/E
16High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

48 plotted
# Industry
1 LLYEli Lilly 45.5% 46.74 $1.36T Pharmaceuticals
2 JNJJohnson & Johnson 7.8% 42.83 $688.76B Pharmaceuticals
3 ABBVAbbVie 10.7% 50.48 $521.69B Pharmaceuticals
4 MRKMerck 4.9% 148.68OUT $364.31B Pharmaceuticals
5 AZNAstrazeneca 7.8% 25.92 $285.96B Pharmaceuticals
6 PFEPfizer 1.3% 40.85 $164.73B Pharmaceuticals
7 VRTXVertex Pharmaceuticals 10.5% 34.34 $136.55B Biotechnology
8 BMYBristol Myers Squibb 4.2% 14.02 $129.66B Pharmaceuticals
9 GSKGsk 82.9% 8.11 $108.86B Pharmaceuticals
10 SNYSanofi -19.6% 6.24 $58.98B Pharmaceuticals
11 TEVATeva Pharmaceutical Industries 2.7% 102.64 $51.97B Generic Drugs
12 ONCBeOne Medicines 32.9% 51.73 $47.53B Pharmaceuticals
13 GEHCGE HealthCare Technologies 6.9% 17.42 $37.54B Diagnostic Equipment
14 ALCAlcon 8.0% 54.90 $36.13B Medical Devices
15 UTHRUnited Therapeutics 1.9% 20.51 $25.06B Pharmaceuticals
16 NBIXNeurocrine Biosciences 38.0% 24.21 $16.96B Pharmaceuticals
17 EXELExelixis 9.1% 19.24 $16.88B Pharmaceuticals
18 BWXTBWX Technologies 17.7% 30.09 $11.27B Nuclear Equipment
19 CORTCorcept Therapeutics 30.0% 48.81 $7.98B Pharmaceuticals
20 AMRXAmneal Pharmaceuticals 8.9% 53.85 $7.45B Generic Drugs
21 FMSFresenius Medical Care AG -49.1% 6.71 $6.16B Healthcare Services
22 EWTXEdgewise Therapeutics 36.6% 4.95 $5.03B Pharmaceuticals
23 OGNOrganon -3.2% 17.14 $3.65B Pharmaceuticals
24 SUPNSupernus 16.3% 7.79 $3.51B Pharmaceuticals
25 TAKTakeda Pharmaceutical -35.4% 10.69 $3.41B Pharmaceuticals
26 ACADAcadia Pharmaceuticals 14.8% 8.93 $3.24B Pharmaceuticals
27 AUPHAurinia Pharmaceuticals 21.0% 6.68 $2.11B Pharmaceuticals
28 HRMYHarmony Biosciences Holdings 19.8% 11.04 $1.98B Pharmaceuticals
29 ETONEton Pharmaceuticals 100.6% 36.75 $1.84B Pharmaceuticals
30 ANIPAni Pharmaceuticals 25.9% 12.97 $1.71B Generic Drugs
31 NRIXNurix Therapeutics 738.8%OUT 5.86 $1.69B Biotechnology
32 JAZZJazz Pharmaceuticals 13.5% 7.59 $1.55B Pharmaceuticals
33 PCRXPacira BioSciences 3.7% 38.52 $1.45B Pharmaceuticals
34 INVAInnoviva 12.8% 7.09 $1.36B Pharmaceuticals
35 COLLCollegium Pharmaceutical 7.7% 21.05 $786.73M Pharmaceuticals
36 DCTHDelcath Systems 38.1% 111.41 $714.55M Medical Devices
37 ZVRAZevra Therapeutics 75.2% 6.91 $539.71M Pharmaceuticals
38 CRMDCorMedix 92.5% 5.90 $370.36M Pharmaceuticals
39 INCYIncyte 24.9% 0.61 $246.78M Pharmaceuticals
40 OMEROmeros 1,532%OUT 2.25 $236.99M Biotechnology
41 SIGASiga Technologies -69.6% 13.22 $196.88M Pharmaceuticals
42 CPIXCumberland Pharmaceuticals 10.7% 1.28 $88.16M Pharmaceuticals
43 VXRTVaxart 22.3% 3.01 $87.73M Biotechnology
44 FBIOFortress Biotech 12.3% 0.65 $62.62M Biotechnology
45 UGUnited Guardian 23.6% 12.43 $38.87M Pharmaceuticals
46 TXMDTherapeuticsMD 33.9% 177.40OUT $21.64M Pharmaceuticals
47 INNPFInnocan Pharma -9.6% 481.28OUT $5.78M Pharmaceuticals
48 PTIXProtagenic Therapeutics, Inc.new -43.1% 0.15 $850.80K Biotechnology

Frequently Asked Questions

Which Pharmaceuticals stocks look cheap relative to their growth?

Among Pharmaceuticals stocks, the largest companies growing revenue faster than the median (12.6%) while trading below the median P/E (15.58) are Gsk (GSK), Edgewise Therapeutics (EWTX), Supernus (SUPN), Acadia Pharmaceuticals (ACAD) and Aurinia Pharmaceuticals (AUPH). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Pharmaceuticals stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Johnson & Johnson (JNJ), AbbVie (ABBV), Merck (MRK), Astrazeneca (AZN) and Pfizer (PFE).

What is the median P/E of Pharmaceuticals stocks?

The median P/E across the 48 Pharmaceuticals stocks plotted is 15.58, with the middle half between 6.86 and 41.34.

What is the median Revenue Growth (1y) (TTM) of Pharmaceuticals stocks?

The median is 12.6%, with the middle half between 4.7% and 30.7%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Pharmaceuticals stocks?

The rank correlation (Spearman) is -0.15, a weak negative relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a lower P/E.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 2 companies are outliers on Revenue Growth (1y) (TTM) and 3 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.